Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype

Migliorini, Gabriele ; Fiege, Bettina ; Hosking, Fay J. ; Ma, Yussanne ; Kumar, Rajiv ; Sherborne, Amy L. ; da Silva Filho, Miguel Inacio ; Vijayakrishnan, Jayaram ; Koehler, Rolf and Thomsen, Hauke , et al. (2013) In Blood 122(19). p.3298-3307
Abstract
Acute lymphoblastic leukemia (ALL) is the major pediatric cancer diagnosed in economically developed countries with B-cell precursor (BCP)-ALL, accounting for approximately 70% of ALL. Recent genome-wide association studies (GWAS) have provided the first unambiguous evidence for common inherited susceptibility to BCP-ALL, identifying susceptibility loci at 7p12.2, 9p21.3, 10q21.2, and 14q11.2. To identify additional BCP-ALL susceptibility loci, we conducted a GWAS and performed a meta-analysis with a published GWAS totaling 1658 cases and 4723 controls, with validation in 1449 cases and 1488 controls. Combined analysis identified novel loci mapping to 10p12.2 (rs10828317, odds ratio [OR] = 1.23; P = 2.30 x 10(-9)) and 10p14marked by... (More)
Acute lymphoblastic leukemia (ALL) is the major pediatric cancer diagnosed in economically developed countries with B-cell precursor (BCP)-ALL, accounting for approximately 70% of ALL. Recent genome-wide association studies (GWAS) have provided the first unambiguous evidence for common inherited susceptibility to BCP-ALL, identifying susceptibility loci at 7p12.2, 9p21.3, 10q21.2, and 14q11.2. To identify additional BCP-ALL susceptibility loci, we conducted a GWAS and performed a meta-analysis with a published GWAS totaling 1658 cases and 4723 controls, with validation in 1449 cases and 1488 controls. Combined analysis identified novel loci mapping to 10p12.2 (rs10828317, odds ratio [OR] = 1.23; P = 2.30 x 10(-9)) and 10p14marked by rs3824662(OR = 1.31; P = 8.62 x 10(-12)). The single nucleotide polymorphism rs10828317 is responsible for the N215S polymorphism in exon 7 of PIP4K2A, and rs3824662 localizes to intron 3 of the transcription factor and putative tumor suppressor gene GATA3. The rs10828317 association was shown to be specifically associated with hyperdiploid ALL, whereas the rs3824662-associated risk was confined to nonhyperdiploid non-TEL-AML1 + ALL. The risk allele of rs3824662 was correlated with older age at diagnosis (P < .001) and significantly worse event-free survivorship (P < .0001). These findings provide further insights into the genetic and biological basis of inherited genetic susceptibility to BCP-ALL and the influence of constitutional genotype on disease development. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Blood
volume
122
issue
19
pages
3298 - 3307
publisher
American Society of Hematology
external identifiers
  • wos:000327466100015
  • scopus:84891671233
  • pmid:23996088
ISSN
1528-0020
DOI
10.1182/blood-2013-03-491316
language
English
LU publication?
yes
id
5458d725-9ff9-4662-855e-8cf2044ee1ca (old id 4274202)
date added to LUP
2016-04-01 10:40:02
date last changed
2022-02-25 03:51:11
@article{5458d725-9ff9-4662-855e-8cf2044ee1ca,
  abstract     = {{Acute lymphoblastic leukemia (ALL) is the major pediatric cancer diagnosed in economically developed countries with B-cell precursor (BCP)-ALL, accounting for approximately 70% of ALL. Recent genome-wide association studies (GWAS) have provided the first unambiguous evidence for common inherited susceptibility to BCP-ALL, identifying susceptibility loci at 7p12.2, 9p21.3, 10q21.2, and 14q11.2. To identify additional BCP-ALL susceptibility loci, we conducted a GWAS and performed a meta-analysis with a published GWAS totaling 1658 cases and 4723 controls, with validation in 1449 cases and 1488 controls. Combined analysis identified novel loci mapping to 10p12.2 (rs10828317, odds ratio [OR] = 1.23; P = 2.30 x 10(-9)) and 10p14marked by rs3824662(OR = 1.31; P = 8.62 x 10(-12)). The single nucleotide polymorphism rs10828317 is responsible for the N215S polymorphism in exon 7 of PIP4K2A, and rs3824662 localizes to intron 3 of the transcription factor and putative tumor suppressor gene GATA3. The rs10828317 association was shown to be specifically associated with hyperdiploid ALL, whereas the rs3824662-associated risk was confined to nonhyperdiploid non-TEL-AML1 + ALL. The risk allele of rs3824662 was correlated with older age at diagnosis (P &lt; .001) and significantly worse event-free survivorship (P &lt; .0001). These findings provide further insights into the genetic and biological basis of inherited genetic susceptibility to BCP-ALL and the influence of constitutional genotype on disease development.}},
  author       = {{Migliorini, Gabriele and Fiege, Bettina and Hosking, Fay J. and Ma, Yussanne and Kumar, Rajiv and Sherborne, Amy L. and da Silva Filho, Miguel Inacio and Vijayakrishnan, Jayaram and Koehler, Rolf and Thomsen, Hauke and Irving, Julie A. and Allan, James M. and Lightfoot, Tracy and Roman, Eve and Kinsey, Sally E. and Sheridan, Eamonn and Thompson, Pamela and Hoffmann, Per and Noethen, Markus M. and Muehleisen, Thomas W. and Eisele, Lewin and Zimmermann, Martin and Bartram, Claus R. and Schrappe, Martin and Greaves, Mel and Stanulla, Martin and Hemminki, Kari and Houlston, Richard S.}},
  issn         = {{1528-0020}},
  language     = {{eng}},
  number       = {{19}},
  pages        = {{3298--3307}},
  publisher    = {{American Society of Hematology}},
  series       = {{Blood}},
  title        = {{Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype}},
  url          = {{http://dx.doi.org/10.1182/blood-2013-03-491316}},
  doi          = {{10.1182/blood-2013-03-491316}},
  volume       = {{122}},
  year         = {{2013}},
}